Louis Isaac Woolf: Pioneer of PKU Treatment and Screening
pplpod · pplpod
Audio is streamed directly from the publisher (content.rss.com) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.
Show Notes
The source provides a comprehensive biographical and professional overview of Louis Isaac Woolf, a distinguished British biochemist who lived from 1919 to 2021. The text highlights his significant contributions to the field of inherited metabolic disorders, particularly his pioneering work on phenylketonuria (PKU). Woolf is credited with advocating for the dietary treatment of PKU—using a low-phenylalanine diet—against the prevailing scientific consensus that the condition was untreatable. Furthermore, the source details his development of early mass screening methods for PKU in newborns, such as the ferric chloride urine test, which led to the first commercial screening product, Phenistix. The overview covers his academic journey, including his studies at University College London and his career at institutions like the Hospital for Sick Children and the University of British Columbia, before his retirement in 1984.